优化炎症性肠病内镜质量:聚焦基于交互式图像和视频教学的结直肠异型增生监测与管理
美国胃肠内镜学会组织、美国克罗恩病和结肠炎基金会认可的炎症性肠病内镜质量优化课程于2015年3月和2016年9月举办,采用交互式病例讨论和授课,课前课后调查显示93%参与者改变了实践,染色内镜使用率从34.3%升至51.7%。
要点
- 课程推荐使用内镜评分系统描述疾病活动度,使用改良Paris分类描述可见异型增生病变。
- 课程推荐使用染色内镜检测异型增生,并对可见异型增生病变行内镜下切除。
- 课后93%参与者表示改变了实践,染色内镜使用率从34.3%升至51.7%。
核心结论
- 内镜在炎症性肠病活动期与静止期病变的特征描述和命名、息肉样与非息肉样异型增生以及结肠炎症性肠病异型增生的检测和管理方面已取得循证进展。
- 将更新后的指南和推荐落实到临床实践,可能通过针对该主题的交互式图像和视频课程来促进。
研究设计与样本
- 美国胃肠内镜学会组织、美国克罗恩病和结肠炎基金会认可的教育活动,由炎症性肠病和内镜专家主导。
- 第一次于2015年3月在伊利诺伊州芝加哥的美国胃肠内镜学会培训与技术研究所举办,第二次于2016年9月在亚利桑那州钱德勒的美国胃肠内镜学会Endofest之前举办。
- 课程包括交互式病例讨论和授课,主题涵盖炎症性肠病监测的原理和当前方法、活动期与静止期疾病的内镜特征和命名、监测中异型增生的检测、图像增强内镜的作用(聚焦染色内镜技术)以及异型增生的管理。
- 18名讲者或专题小组成员和约92名炎症性肠病及内镜医师领导者参会;参与者在课程前后接受调查以评估观点和实践。
主要发现
- 大多数参会者年龄30至49岁(88.1%),执业少于10年(89.7%),来自学术医学中心(90.7%),超过50%的时间用于诊治炎症性肠病患者(59.7%)。
- 随访调查中,93%参与者表示因参加课程而改变了实践。
- 对于异型增生检测,染色内镜使用增加:51.7%的受访者报告在大多数监测结肠镜检查中使用染色内镜,而课程前为34.3%。
- 对于异型增生管理,10至20 mm的息肉样和非息肉样病变使用内镜下黏膜切除术增加;20 mm或更大且内镜下可切除的异型增生病变的转诊转向由经验丰富的内镜医师切除。
关键数值与推荐
- 推荐的质量改进包括使用内镜评分系统描述疾病活动度。
- 推荐使用改良Paris分类描述可见异型增生病变(息肉样、非息肉样并描述有无溃疡及边界清晰或不清晰)。
- 推荐使用染色内镜检测异型增生。
- 推荐对可见异型增生病变行内镜下切除。
临床怎么用
- 课程推荐使用内镜评分系统描述炎症性肠病疾病活动度。
- 课程推荐使用改良Paris分类描述可见异型增生病变。
- 课程推荐使用染色内镜检测异型增生,并对可见异型增生病变行内镜下切除。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Varying recommendations regarding the detection and management of dysplasia can lead to uncertainty and may impede the uptake of strategies that could improve surveillance in patients with inflammatory bowel disease (IBD). An educational event was held to assist in disseminating the recently published Surveillance for Colorectal Endoscopic Neoplasia Detection and Management in Inflammatory Bowel Disease Patients: International Consensus Recommendations (SCENIC). METHODS: Specialists in IBD and endoscopy led the Optimizing Quality of Endoscopy in IBD course. The American Society for Gastrointestinal Endoscopy (ASGE) organized the course, and the Crohn's and Colitis Foundation of America (CCFA) provided endorsement. One was held in March 2015 at the ASGE Institute for Training and Technology in Chicago, Illinois, and the second in September 2016 preceding the ASGE Endofest in Chandler, Arizona. The program included interactive case-based discussions and didactic presentations on topics including the rationale and current approach of surveillance in IBD; endoscopic characterization and nomenclature of active and quiescent disease; detection of dysplasia during IBD surveillance; role of image-enhanced endoscopy in IBD surveillance, with a focus on chromoendoscopy technique; and management of dysplasia in IBD. Participants were surveyed before and after the course to assess their perspectives and practice. RESULTS: Eighteen presenters or panel members and approximately 92 IBD and endoscopist physician leaders attended the meeting. Most attendees were aged 30 to 49 years (88.1%), had been in practice less than 10 years (89.7%), were from academic medical centers (90.7%), and spent >50% of their time caring for patients with IBD (59.7%). Recommended quality improvements for endoscopy in IBD included the use of endoscopic scoring systems to describe disease activity, the use of a modified Paris classification to characterize visible dysplastic lesions (polypoid, nonpolypoid with description of presence of ulcer and distinct or indistinct borders), the use of chromoendoscopy for dysplasia detection, and the endoscopic removal of visible dysplastic lesions. In the follow-up survey, participants were asked to indicate whether they had changed their practice as a result of attending the course. Ninety-three percent (93%) indicated they had changed their practice. For dysplasia detection, the use of chromoendoscopy increased: 51.7% of respondents reported using chromoendoscopy in most surveillance colonoscopies compared with 34.3% before the course. For dysplasia management, the use of EMR increased for polypoid and nonpolypoid lesions 10 to 20 mm in size; and the referral of dysplastic lesions 20 mm or larger that appeared endoscopically resectable shifted toward removal by an experienced endoscopist. CONCLUSIONS: Evidence-based advances in endoscopy have occurred in the characterization and nomenclature of active and quiescent disease, polypoid and nonpolypoid dysplasia in IBD, and in the detection and management of dysplasia in colonic IBD. Implementation of updated guidelines and recommendations into clinical practice may be facilitated by interactive image- and video-based courses on the topic.
引用
- Kaltenbach TR, Soetikno RM, DeVivo R, et al. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching. Gastrointest Endosc. 2017. PMID: 28818507. doi:10.1016/j.gie.2017.07.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。